Pneumonia scoring systems for severe COVID-19: which one is better.

Pneumonia scoring systems for severe COVID-19: which one is better.
复制标题

重症 COVID-19 肺炎评分系统:哪一个更好

DOI:
10.1186/s12985-021-01502-6
复制
发表时间:
2021-02-10
期刊:
影响因子:
4.8
通讯作者:
Zhou X
Zhou X
中科院分区:
医学3区
文献类型:
--
作者:
Cheng P;Wu H;Yang J;Song X;Xu M;Li B;Zhang J;Qin M;Zhou C;Zhou X

文献摘要

参考文献

被引文献

相似文献

目的探讨不同肺炎评分系统对重症新型冠状病毒肺炎患者临床严重程度及死亡风险的预测意义。材料与方法报告53例新型冠状病毒感染的重症肺炎确诊病例。计算不同治疗方法的APACHE II、MuLBSTA和CURB-65评分,比较各评分对临床呼吸支持治疗和死亡风险的预测能力。结果在无创和有创呼吸支持治疗评估中,APACHE II评分的ROC曲线下面积最大,与CURB-65评分差异有统计学意义。此外,在死亡风险评估方面,MuLBSTA评分的ROC曲线下面积最大,与CURB-65也有显著差异;然而,APACHE II评分没有差异。结论对于COVID患者,APACHE II评分是疾病严重程度和死亡风险的有效预测指标。此外,MuLBSTA评分仅在死亡风险方面是一个很好的预测指标。
PurposeTo investigate the predictive significance of different pneumonia scoring systems in clinical severity and mortality risk of patients with severe novel coronavirus pneumonia.Materials and methodsA total of 53 cases of severe novel coronavirus pneumonia were confirmed. The APACHE II, MuLBSTA and CURB-65 scores of different treatment methods were calculated, and the predictive power of each score on clinical respiratory support treatment and mortality risk was compared.ResultsThe APACHE II score showed the largest area under ROC curve in both noninvasive and invasive respiratory support treatment assessments, which is significantly different from that of CURB-65. Further, the MuLBSTA score had the largest area under ROC curve in terms of death risk assessment, which is also significantly different from that of CURB-65; however, no difference was noted with the APACHE II score.ConclusionFor patients with COVID, the APACHE II score is an effective predictor of the disease severity and mortality risk. Further, the MuLBSTA score is a good predictor only in terms of mortality risk.
预测病毒性肺炎患者死亡风险的临床特征:MuLBSTA 评分
DOI: 10.3389/fmicb.2019.02752
发表时间: 2019-12-03
影响因子: 5.2
作者:
Guo, Lingxi;Wei, Dong;Qu, Jieming
通讯作者: Qu, Jieming
DOI: 10.1016/j.ijid.2014.11.005
发表时间: 2015-01-01
影响因子: 8.4
作者:
Zhou, Xiao-Yu;Ben, Su-Qin;Ni, Song-Shi
通讯作者: Ni, Song-Shi
严重的社区获得性肺炎:通风和非通风患者的特征和预后因素。
DOI: 10.1371/journal.pone.0191721
发表时间: 2018
期刊: PloS one
影响因子: 3.7
作者:
Ferrer M;Travierso C;Cilloniz C;Gabarrus A;Ranzani OT;Polverino E;Liapikou A;Blasi F;Torres A
通讯作者: Torres A
DOI: 10.5644/ama2006-124.165
发表时间: 2016-11-01
影响因子: --
作者:
Godinjak, Amina;Iglica, Amer;Kukuljac, Adis
通讯作者: Kukuljac, Adis
DOI: 10.1016/j.medcli.2017.06.044
发表时间: 2018-02-09
期刊: MEDICINA CLINICA
影响因子: 3.9
作者:
Murillo-Zamora, Efren;Medina-Gonzalez, Alfredo;Trujillo-Hernandez, Benjamin
通讯作者: Trujillo-Hernandez, Benjamin